Next, we asked if targeting the Wnt pathway via use of a PORCN inhibitor would reverse the phenomena of T cell exclusion and promote a hot TME in a clinically relevant pre-clinical murine model of ovarian cancer. This evidence concerns the gene PORCN and ovarian carcinoma.